KemPharm uses its LAT platform technology to discover and develop prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety.
|Recent News||More >>|
KemPharm, Inc. Reports Second Quarter 2016 Results
KemPharm, Inc. to Report Second Quarter 2016 Results
KemPharm to Present at Canaccord Genuity 36th Annual Growth Conference
|Upcoming Events||More >>|
|There are currently no events scheduled.|
|Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources|